Conclusion Aerosol inhalation of budesonide combined with ambroxol in treatment of acute exacerbation of COPD has good efficacy, no adverse reactions, is worthy of clinical use.
结论布地奈德联合氨溴索雾化吸入治疗COPD急性加重期疗效好，无明显不良反应，值得临床推广使用。
Objective To observe the clinical effect of treating the acute episode of infantile asthma with aerosol inhalation of budesonide and salbutamol sulphate.
目的观察布地奈德联合硫酸沙丁胺醇雾化吸入治疗小儿哮喘急性发作的临床疗效。
CONCLUSION: Based on recent evidence in China, aerosol inhalation of budesonide combined with conventional therapy contributes to the treatment of children pneumonia.
结论：基于目前国内临床证据，在常规治疗基础上加用布地奈德雾化吸入，有利于小儿肺炎治疗。
应用推荐